XML 86 R73.htm IDEA: XBRL DOCUMENT v3.23.2
Investments in and Advances to Joint Ventures - Summary of Financial Information for Unconsolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 1,980,208   $ 1,980,208   $ 1,719,783
Total assets 4,507,507   4,507,507   4,198,142
Current liabilities 1,294,901   1,294,901   1,108,119
Total liabilities 2,316,741   2,316,741   2,102,207
Total joint venture equity 2,119,431   2,119,431   2,043,570
Investments in and advances to unconsolidated joint ventures 118,861   118,861   107,425
Revenue 1,356,486 $ 1,008,721 2,529,952 $ 1,957,790  
Costs 1,068,220 781,772 1,985,408 1,515,672  
Net income attributable to Parsons Corporation 43,241 18,295 68,794 38,962  
Equity in (losses) earnings of unconsolidated joint ventures 75 5,613 (5,765) 11,211  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 1,470,305   1,470,305   1,610,246
Noncurrent assets 492,597   492,597   491,658
Total assets 1,962,902   1,962,902   2,101,904
Current liabilities 1,032,758   1,032,758   1,255,297
Noncurrent liabilities 518,762   518,762   468,056
Total liabilities 1,551,520   1,551,520   1,723,353
Total joint venture equity 411,382   411,382   378,551
Investments in and advances to unconsolidated joint ventures 118,861   118,861   $ 107,425
Revenue 530,467 594,959 879,624 979,540  
Costs 534,555 564,239 893,950 937,525  
Net income attributable to Parsons Corporation (4,088) 30,720 (14,326) 42,015  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Equity in (losses) earnings of unconsolidated joint ventures $ 75 $ 5,613 $ (5,765) $ 11,211